Discover trends, market shifts, and competitive outlooks for the ventricular assist device industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#What Is the Current and Projected Market Size of the Ventricular Assist Device Market Through 2034?

The market size for ventricular assist devices has seen swift expansion in recent times. It is projected to rise from $2.12 billion in 2024 to around $2.39 billion in 2025, reflecting a Compound Annual Growth Rate (CAGR) of 12.6%. This growth during the historical period is fundamentally driven by a surge in heart failure cases and increased need for organ transplant procedures.

The market size for ventricular assist devices is projected to experience swift expansion in the coming years. It’s estimated to reach $3.91 billion by 2029, with a compound annual growth rate (CAGR) of 13.1%. A number of factors can be credited for the anticipated growth during the forecast period including the rising requirement for destination therapy, the aging population, hikes in healthcare spending, and increased awareness about heart failure treatments. Some major trends to watch for during the forecast period involve initiatives to improve VAD longevity, efforts to make VADs smaller, advanced pump technologies, emphasis on the safety and efficiency of VADs, attempts to decrease VAD side effects and the emergence of percutaneously inserted ventricular assist devices.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6680&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Ventricular Assist Device Market?

The escalated occurrence of cardiovascular ailments is a primary stimulant for the expansion of the ventricular assist device market. Such heart conditions arise from factors including elevated blood pressure, smoking, heightened cholesterol levels, a lack of physical activity, among others. In addition, non-infectious diseases like diabetes, chronic respiratory illness, and hypertension-induced heart attacks contribute to the rise in cardiovascular disorders. This surge is likely to amplify the requirement for ventricular assist devices that play an essential role in supporting gravely sick cardiac patients. As reported by the National Library of Medicine, an American federal agency, as of October 2022, it is projected that by 2035, cardiovascular disease will afflict 45.1% of the American populace. Predictions suggest that the total expenditure related to these heart ailments will escalate to $1.1 trillion by 2035. Thus, the mounting occurrence rate of cardiovascular ailments is likely to spur the demand for ventricular assist devices in the future.

Which Key Market Segments Comprise the Ventricular Assist Device Market and Drive Its Revenue Growth?

The ventricular assist device market covered in this report is segmented –

1) By Product: Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), Biventricular Assist Devices (BIVADs).

2) By Type: Pulsatile Flow, Continuous Flow

3) By Design: Transcutaneous Ventricular Assist Devices, Implantable Ventricular Assist Devices

4) By Application: Bridge-To-Transplant (BTT) Therapy, Destination Therapy, Bridge-To-Recovery (BTR) Therapy, Bridge-To-Candidacy (BTC) Therapy

5) By End Users: Hospital, Ambulatory Surgical Centres, Cardiology Centres

Subsegments:

1) By Left Ventricular Assist Devices (LVADs): Implantable LVADs, Temporary LVADs

2) By Right Ventricular Assist Devices (RVADs): Implantable RVADs, Temporary RVADs

3) By Biventricular Assist Devices (BIVADs): Full Support BIVADs, Hybrid BIVADs

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=6680&type=smp

Which Areas Are Leading Regions in the Ventricular Assist Device Market Expansion Across the Globe?

North America was the largest region in the ventricular assist device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ventricular assist device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Key Market Trends in theVentricular Assist Device Market Over the Coming Years?

Ventricular assist devices that are inserted percutaneously are seeing an increased demand within the market. Essentially, they are non-pulsatile axial flow pumps that are positioned across the aortic valve, pumping blood from the left ventricle. The benefits of a percutaneously inserted ventricular assist device (VAD) include decreased pressure on the left ventricle, reduced myocardial oxygen consumption, improved cardiac output, and a reduction in left ventricular end-diastolic pressure. In August 2022, a company based in the US called Abiomed Inc. released Impella, a percutaneous VAD designed for eligible pediatric patients in the US. With the ability to significantly support the cardiac function in patients with a failed left ventricle, the device can function as a replacement for extracorporeal membrane oxygenation (ECMO), or accompany other therapies to enhance hemodynamics.

View the full report here:

https://www.thebusinessresearchcompany.com/report/ventricular-assist-device-global-market-report

How Is the Ventricular Assist Device Market Conceptually Defined?

A ventricular assist device refers to an implantable mechanical circulatory device used to treat heart failure by pumping blood from the heart to the rest of the body, improving circulation to vital organs. A wide range of ventricular assist devices are approved by the US FDA to provide long-term or permanent support to patients with end-stage heart failure.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6680

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model